Delta Medical Secures￥150M in Series E Funding, Led by CDH Investments

(VCBeat) Feb. 8, 2021 -- Beijing-based Delta Medical, a well-known company in the sports medicine industry, announced today that it had successfully closed on a ￥150 million Series E financing, less than half a year after its last financing of over 100 million RMB. This round of financing was led by CDH Investments, with participation from existing investors Qiming Venture Partners and Insight Capital. 

Proceeds from the transaction will be used for Delta Medical's business expansion, product promotion, new production base construction and recruitment.

Delta Medical is energetically dedicated to sports medicine surgery providing a full range of arthroscopic devices covering metal/Peek suture anchors, interference screws, buttons, ultra-high-strength sutures w/o needles, arthroscopic instrument sets, as well as postsurgical and rehabilitation braces. 

Delta Medical always adheres to the R&D concept of equal emphasis on clinical application and technology. 

In terms of clinical application, Delta Medical has in-depth cooperation with well-known experts in the industry to provide the best solutions for clinical needs and is committed to improving surgical efficiency and the final effect of surgery. At present, the company has built modern production bases and R&D centers in Beijing, Sichuan, and Liaoning.

Centered on the two areas of sports medicine -- new materials and minimally invasive technology, the core products independently developed by Delta Medical have the biomechanical design more suitable for the human body structure and are made of the most advanced composite materials.

Established in 2002, CDH is one of the leading alternative investment fund managers focused on China today with over US$19 billion of assets under management, as of February 31, 2020. From its roots in private equity, CDH has expanded to become a diversified alternative asset management platform covering: Private Equity, Real Assets, Venture and Growth Capital, Mezzanine & Credit, Public Equities and Wealth Management.

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Shenzhen, Hong Kong, Seattle, Boston, and San Francisco Bay Area. Currently, Qiming Venture Partners manages seven US Dollar funds and five RMB funds with over US$4 billion assets under management. Qiming Venture Partners invests in information technology, new consumer business patterns, and the healthcare sector.